Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Limbal epithelial stem cells are critical adult unipotent progenitors responsible for lifelong renewal and repair of human corneal epithelium. Their deficiency leads directly to severe ocular surface disease with significant morbidity. Advances in bioengineering have enabled successful clinical therapies based on isolation/expansion/transplantation approaches targeting this unique cell population for sight restoration in affected patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Limbal Epithelial Stem Cell.